title: Grading system and management guidelines for dermatitis induced by head and neck radiotherapy plus cetuximab: clinical validation required.
authors: J A
authors: JA
authors: Langendijk
authors: S F
authors: SF
authors: Oosting
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D000068818:Cetuximab; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D018787:Radiation Oncology / Q000592:standards*; D011855:Radiodermatitis / Q000209:etiology* / Q000473:pathology*; D000077195:Squamous Cell Carcinoma of Head and Neck
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab